Text Size

Relation of Blood-boron Levels With Body Mass Index

This study is not yet open for participant recruitment.
Verified July 2011 by SB Istanbul Education and Research Hospital
Sponsor:
Information provided by:
SB Istanbul Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT01400061
First received: July 21, 2011
Last updated: NA
Last verified: July 2011
History: No changes posted
  Purpose

According to our experimental experiences w hypothesized that blood boron levels may be corralated to body mass index.


Condition
Obesity

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Phase 1 Study of Blood Boron Levels According to Body Mas Index

Resource links provided by NLM:

MedlinePlus related topics: Obesity
Drug Information available for: Boron
U.S. FDA Resources

Further study details as provided by SB Istanbul Education and Research Hospital:

Primary Outcome Measures:
  • blood boron level [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
    blood boron levels will be measured cantitatively


Secondary Outcome Measures:
  • body mass index [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
    body mass index levels will be evaluated with blood boron levels


Biospecimen Retention:   Samples Without DNA

blood serum analyses


Estimated Enrollment: 80
Study Start Date: August 2011
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
normal
body mass index: 19-24
overweight
body mass index: 25-29
obesity
body mass index: 30-40
modbid obes
body mass index: over 40

Detailed Description:

In the results of our experimental study on mices we revealed that low dose oral boric acid intake cause seriously body mas reducing. Although blood and urine analyses support high glucose, lipid and middle protein catabolisms, but the mechanism was unclear. There are some diseases according to blood elementary deficiencies, like hypothyroidi in hypoiyodinemia, hiperparathyroidi in hypocalcemia, etc. We hypothesised that hypoboronemia may be corralated to body mass index level.

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Normal: 19-24 Overweight: 25-29 Obes: 30-40 Morbid Obes: >40

Criteria

Inclusion Criteria:

  • body mas index levels in over 19 peoples

Exclusion Criteria:

  • known chronic, morbid and malign diseases
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01400061

Contacts
Contact: erhan aysan, assoc. prof. +902124531700
Contact: gokhan cipe, MD +902124531700

Locations
Turkey
Bezmialem Vakif University
Istanbul, Turkey, 34543
Sponsors and Collaborators
SB Istanbul Education and Research Hospital
Investigators
Study Chair: adnan yuksel, prof rector
  More Information

Publications:

Responsible Party: Bezmialem Vakif University, bezmialem vakif university
ClinicalTrials.gov Identifier: NCT01400061     History of Changes
Other Study ID Numbers: bor1
Study First Received: July 21, 2011
Last Updated: July 21, 2011
Health Authority: Turkey: Ministry of Health

Keywords provided by SB Istanbul Education and Research Hospital:
obesity, etiology, pathogenesis, treatment

Additional relevant MeSH terms:
Obesity
Overnutrition
Nutrition Disorders
 Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on May 19, 2013